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Abstract 
There is accumulating evidence that interactions between epidermal melanocytes and 
stromal cells play an important role in the regulation of skin pigmentation. In this study we 
established a pigmented dermo-epidermal skin model (melDESS) of human origin to 
investigate the effects of distinct stromal cells on melanogenesis. melDESS is a complex, 
clinically relevant skin equivalent composed of an epidermis containing both melanocytes 
and keratinocytes. Its dermal compartment consisted either of adipose tissue-derived stromal 
cells (ASC), dermal fibroblasts, or a mixture of both cell types. These skin substitutes were 
transplanted for five weeks on the backs of immuno-incompetent rats and analyzed. 
            Gene expression and western blot analyses showed a significantly higher expression 
of transforming growth factor-β1 (TGF-β1) by ASC in comparison to dermal fibroblasts. In 
addition we showed that melanocytes responded to the increased levels of TGF-β1 by down-
regulating the expression of key melanogenic enzymes such as tyrosinase. This caused 
decreased melanin synthesis and consequently greatly reduced pigmentation of melDESS.  
The conclusions are of utmost clinical relevance, namely that that ASC derived from 
the hypodermis fail to appropriately interact with epidermal melanocytes thus preventing the 
sustainable restoration of the patient’s native skin color in bio-engineered skin grafts. 
 
Introduction  
Human epidermal melanocytes are derived from the neural crest and reside in the stratum 
basale. They produce melanin - the pigment responsible for the skin color, package melanin 
into melanosomes, and transfer those to keratinocytes. The basic mechanism for melanin 
pigmentation is multicellular in design, consisting of a melanocyte and an associated 
population of keratinocytes, the functional epidermal melanin unit (EMU) (Ando et al., 2012). 
Melanin is stored within specific cytosolic organelles called melanosomes. Further, 
melanosomes can be transferred from melanocytes to epidermal keratinocytes to provide 
protection against ultraviolet (UV) light induced DNA damage, hence decrease the risk of 
mutations and skin cancer (Hearing et al., 1999). 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3 
In general, melanin biosynthesis is regulated by at least three specific enzymes, 
namely tyrosinase (TYR), tyrosinase-related protein 1 (TRP1) (Kobayashi et al., 1994), and 
tyrosinase-related protein 2 (TRP2; DCT) (Yokoyama et al., 1994). Among these enzymes, 
tyrosinase is the key enzyme catalyzing the rate-limiting step in melanin biosynthesis. The 
tyrosinase-related genes -TRP1 and TRP2 are under the control of the master transcriptional 
regulator of melanocyte differentiation and development - MITF (Microphthalmia 
Transcription Factor) (Bertolotto et al., 1998).  
Moreover, two members of the SRY-box (SOX)-containing family of transcription 
factors play important roles in regulating melanocyte development (Harris et al., 2010). SOX9 
has been implicated in melanocyte differentiation in the adult, whereas SOX10 is essential 
for the maintenance, migration, and specification of neural crest cells (NCCs) during 
embryogenesis (Cook et al., 2005). SOX9 is up-regulated by UVB exposure. In melanocytes, 
SOX9 increases the expression of MITF, TRP2, and tyrosinase promoters, leading to a 
stimulation of pigmentation (Passeron et al., 2007). In contrast, the high expression of 
SOX10 in unpigmented precursor cells is down-regulated as they differentiate into 
melanocytes (Cook et al., 2003, Greenhill et al., 2011, Harris et al., 2013). However, SOX10 
expression is never fully abolished in differentiated melanocytes. It may still persist at lower 
levels in the adult, as SOX10 has also an important function at later melanocyte 
differentiation stages by activating MITF and TYR expression (Huber et al., 2003). However, 
the exact interplay between those different transcription factors and their impact on the 
maintenance of premature human melanocytes (melanoblasts) and their differentiation in 
human skin have not yet been fully characterized. 
Increasing evidence suggests that, in addition to keratinocytes, stromal cells present 
in the human dermis are significantly involved in the regulation of skin pigmentation 
(Biedermann et al., 2015b). Yamaguchi et al. suggested that Dickkopf 1 (DKK1), an inhibitor 
of the Wnt signaling pathway produced by fibroblasts in the palms and soles, has an 
inhibitory effect on melanocyte proliferation and function, leading to a hypopigmentation of 
these body sites (Yamaguchi et al., 2008b, Yamaguchi et al., 2004).  
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We have recently successfully used adipose-derived mesenchymal stromal cells 
(ASC) to generate dermo-epidermal skin substitutes (Klar et al., 2014). ASC were shown to 
secrete different growth factors and cytokines, which improve wound healing by a paracrine 
mechanism (Kim et al., 2008a, Kim et al., 2008b) and show anti-oxidant effects (Kim et al., 
2009a). Transforming growth factor-β1 (TGF-β1), one of the factors detected in the 
conditioned medium from ASC (ASC-CM), was shown in 2D cultures to inhibit melanin 
biosynthesis in B16 melanoma cells (Kim et al., 2008a, Martinez-Esparza et al., 1997). TGF-
β1 regulates transcription (Shi and Massague et al., 2003) of various target genes such as 
MITF (Kim et al., 2004, Nishimura et al., 2010). Further, the reduced expression of MITF - 
the master regulator in melanocytes, inhibits the expression of its downstream effectors such 
as TYR and TRP1. 
Although ASC were shown to be a promising cell source for skin equivalents (Klar et 
al., 2014), there have been no reports about the direct effects of ASC on melanocytes in a 
3D in vivo skin model. Therefore, we studied the influence of ASC on melanogenesis in a 
pigmented bio-engineered dermo-epidermal skin model (melDESS) in vivo. We found that 
ASC suppressed melanocyte differentiation and skin pigmentation via inhibited melanin 
production by increased secretion of TGF- β1. 
 
Results 
The effect of the human ASC secretome on melanin production and proliferation of 
human epidermal melanocytes  
The effect of human ASC-conditioned medium (ASC-CM) on the melanogenic activities of 
primary epidermal melanocytes was tested. When cultured in standard melanocyte growth 
medium (herein referred to as melanocyte medium) on culture plastic, melanocytes 
expressed PMEL. PMEL (PMEL17/gp100/premelanosome protein) is an amyloid fibril 
forming protein, specifically expressed in melanosomes and detectable by a HMB45 antibody 
(Raposo et al., 2001). 
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Under these culture conditions almost all PMEL+ cells showed the expression of 
tyrosinase (TYR) (94 ± 3%) (Figure 1a,g, Figure S1a-c), tyrosinase-related protein 1 (TRP1) 
(97 ± 5%) (Figure 1b,g, Figure S1d-f), and tyrosinase-related protein 2 (TRP2) (97 ± 3 %) 
(Figure 1c,g, Figure S1g-i).  
 Treating these melanocytes with ASC-CM for 72 hours markedly decreased the 
expression of TYR (8 ± 3%; p<0.0001) (Figure 1d,g; S1j-l) and TRP1 (9 ± 2%, p<0.0001) 
(Figure 1e,g, S1m-o), whereas it only marginally reduced the TRP2 (81 ± 6%; p=0.0111) 
(Figure 1f,g; S1p-s) expression in the PMEL+ melanocytes. Of note, the intensity of PMEL 
expression did not change in melanocytes upon addition of ASC-CM. However, the number 
of melanocytes was reduced by this treatment. 
Moreover, melanocytes grown in ASC-CM showed lower cell numbers than control 
melanocytes cultured in melanocyte medium (Figure 1d-f; S1a-s). ASC-CM treated 
melanocytes exhibited small and bipolar cell bodies with a reduced number of dendrites, 
which is characteristic of melanocyte precursors (Nishimura et al., 2010). Visual inspection of 
the color of melanocyte pellets confirmed that ASC-CM caused a noticeable decrease of 
melanin content as compared to the control (Figure 1h). 
Melanin content in melanocytes treated with ASC-CM was determined by a 
biochemical melanin assay (Figure 1h,i) (Bilodeau et al., 2001). Melanocytes cultured in 
ASC-CM showed significantly lower melanin content (14 ± 12 µg) as compared to those 
cultured in melanocyte medium (65 ± 11 µg). However, the downregulation of melanin 
synthesis by ASC-CM was almost fully reversed upon supplementing with melanocyte 
medium (47 ± 16 µg) (Kim et al., 2008a). 
 
Comparison of factors secreted by human ASC and dermal fibroblasts 
We have screened the expression of different cytokines such as DKK1, tumor necrosis factor 
(TNF)-α, interleukin (IL)-6, and Agouti-signaling protein (ASIP; MC1R antagonists) in both 
ASCs and dermal fibroblasts (Figure S2). Those factors were described in the literature as 
paracrine inhibitors of human melanocyte proliferation, tyrosinase activity, and 
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melanogenesis in human skin (Yamaguchi and Hearing et al., 2009; Wolf Horrell et al., 
2016)).  Notably, we did not observe a statistically significant difference in the expression of 
DKK1, IL-6, and ASIP when comparing ASCs and normal dermal fibroblast (not palmoplantar 
fibroblasts as reported by Yamaguchi et al., 2008b) (Figure S2). We observed a moderate 
upregulation of TNF-α mRNA in ASCs (Figure S2). Nevertheless, it was reported previously 
that the concentration of TNF-α in ASC-CM is much lower than its half-maximal inhibitory 
concentration (IC50) for having an inhibitory effect on melanocyte proliferation and 
melanogenesis (Kilroy et al., 2007, Kim et al., 2008a, Kim et al., 2008b). 
Finally we observed a highly upregulated TGF-β1 mRNA and protein expression in 
ASC as compared to dermal fibroblast (Figure 2). Therefore, we concluded that TGF-β1 
mediates most of the anti-melanogenic effects of ASC-CM in this study. 
Figure 2a demonstrates TGF-β1-specific mRNA as shown by a band of the correct 
molecular weight. TGF-β1 mRNA was thus produced by both ASC and dermal Fb. However, 
TGF-β1 mRNA expression was almost 3-fold higher in ASC than in dermal Fb (p=0.0037) 
(Figure 2b).  
Similar results were obtained analyzing protein levels. Western blot analyses 
revealed a 3-fold higher expression of TGF-β1 in ASC-cell lysates when compared to dermal 
Fb (Figure 2c).  
Interestingly, ELISA measurements also revealed a significant difference in the 
concentration of TGF-β1 in conditioned media of both cell types (Figure 2d). TGF-β1 
concentrations in ASC-CM were 2.4-fold higher than in dermal Fb-CM (200 ± 25 pg/ml and 
84 ± 40 pg/ml; p=0.0028, respectively). 
 
Skin pigmentation in human dermo-epidermal skin substitutes is regulated by stromal 
cells 
We previously reported that bio-engineered pigmented dermo-epidermal skin substitutes 
(melDESS) composed of dermal fibroblasts (dermal compartment) and keratinocytes with 
melanocytes (epidermal compartment) from either dark or light donor skin, resulted in a 
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donor skin-matched dark or light coloration of those skin grafts, respectively (Bottcher-
Haberzeth et al., 2013).  
In this study, we investigated the influence of human dermal FB and ASC on 
pigmentation in melDESS in vivo. A hypothetical view comparing these two different models 
in vivo is depicted in Figure 7. From this model, it is evident that those two different types of 
stromal cells cause different effects on epidermal melanocytes in bio-engineered skin 
equivalents. 
 melDESS were transplanted on the backs of immune-deficient ralents.ts and excised 
after five weeks for analysis (Figure 3). Human dermal fibroblasts derived from dark 
pigmented donor skin were used in control skin substitutes (Figure 3a). We also included in 
the study melDESS containing a mixture of dermal Fb and ASC (dermal Fb/ASC) in a 1:1 
ratio (Figure 3b). The epidermis contained the same keratinocytes and melanocytes isolated 
from dark pigmented donor skin in all three skin substitutes. Thus, solely the impact of the 
stromal cell component on melanocyte proliferation, skin pigmentation, and marker 
expression was investigated in vivo. 
Five weeks after transplantation, the human skin substitutes containing dermal Fb 
showed intense dark pigmentation (Figure 3a), hence resembling the dark pigmented donor 
skin. Macroscopic evaluation of skin substitutes containing the mixed population of dermal 
Fb and ASC showed a slightly brown pigmented skin color (Figure 3b), whereas substitutes 
containing only ASC remained as a white, non-pigmented skin (Figure 3c). Skin pigmentation 
was homogenously distributed throughout the entire transplant in all groups.  
Fontana Masson staining was undertaken to visualize melanin granules in the 
different skin substitutes. The staining demonstrated high melanin abundance in the basal 
layer and in supranuclear caps of keratinocytes in skin transplants containing dermal Fb 
(Figure 3d). In contrast, mixed transplants containing both Fb and ASC in the dermal part 
showed very low melanin content in basal epidermal cells and lacked the supranuclear 
keratinocyte melanin caps. Only some melanin granules were randomly distributed 
throughout all the epidermal keratinocyte layers (Figure 3e). Finally, in skin substitutes 
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containing ASC, melanin was only observed in few basal cells, whereas almost no melanin 
was found in suprabasal epidermal keratinocytes (Figure 3f).  
MITF immunofluorescence of skin transplants revealed that melanocytes resided at 
the proper physiological location in the basal layer of the epidermis in all three skin 
specimens (Figure 3g-i). However, as demonstrated by the quantification in Figure 3j, the 
number of MITF-positive melanocytes was higher in the dermal Fb-group (18 ± 4) as 
compared the group containing a mixture of dermal Fb and ASC (12 ± 5, p=0.0058). 
Importantly, the presence of pure ASC in the dermal compartment of melDESS led to a 
statistically significant decrease in the mean melanocyte number in the epidermal basal layer 
(8 ± 3, p< 0.0001) (Figure 3j).  
 
Decreased expression of TYR and TRP1 in ASC-containing melDESS in vivo  
To assess cell density and melanocyte differentiation in transplanted skin substitutes, we 
performed combined immunostainings for PMEL, TYR, TRP1, and Ki67 (Figure 4a-f, S3a-d ). 
The number of TYR+PMEL+ melanocytes in ASC-containing samples was significantly 
reduced as compared to skin substitutes containing dermal Fb (98 ± 5% vs. 11 ± 5%; p< 
0.0001) (Figure 4a-c). Interestingly, melanocytes in skin transplants containing both dermal 
Fb and ASC expressed TYR at an intermediate level (60 ± 1% of all PMEL cells) (Figure 
S3a,c). 
Additionally, TRP1, which is characteristic for late stage III or IV pigmented 
melanosomes, was expressed at a significantly lower level in ASC-containing specimens as 
compared to the dermal Fb-group (95 ± 10% vs. 3± 5%; p< 0.0001) (Figure 4d-f). In dermal 
Fb/ASC containing transplants the mean of 65 ± 5% of all PMEL+ melanocytes expressed 
TRP1 (Figure S3b,c). In contrast, TRP2 was expressed at comparable levels in all three 
transplant groups (data not shown). These finding suggest that ASC-CM blocks melanosome 
biogenesis in epidermal melanocytes at stage II. 
Quantification of Ki67+ melanocytes in the ASC-group showed that only about 15 ± 
7% of PMEL+ melanocytes were proliferating as compared to 54 ± 20% in the control group  
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containing dermal Fb (Figure S3c-d) (p=0.0096). In skin transplants containing both Fb and 
ASC, a population of 43 ± 26% of proliferating melanocytes was detected (Figure S3c).  
 
Differential expression of SOX proteins in melanocytes in ASC-containing melDESS in 
vivo 
To further assess the differentiation status of melanocytes in the distinct skin substitutes, 
sections of skin transplants were stained with either SOX9 or SOX10 antibodies, which are 
characteristic for mature or immature melanocytes, respectively (Figure 4g-l).  
Immunofluorescence analyses of SOX9 on skin transplants containing dermal Fb 
revealed that the vast majority of PMEL+ melanocytes were positive for this differentiation 
marker (95 ± 7% of PMEL+ cells) (Figure 4g,j). This finding is line with data we observed in 
normal human skin (data not shown). In contrast, melDESS containing ASC showed a 
significant reduction of SOX9 expression (40 ± 1% of PMEL+ cells) (Figure 4h,i). Expression 
levels of SOX9 in skin transplants containing both Fb and ASC were similar to the dermal Fb-
group accounting for 89 ± 5% of Sox9+PMEL+ cells (Figure S4). 
Using a SOX10-specific antibody we observed just the opposite result as 
demonstrated in Figure 4j-l. Whereas only 39 ± 14% of melanocytes in the dermal Fb-group 
were SOX10-positive (Figure 4j,l), its expression increased to 81 ± 13% in the ASC-
containing melDESS (Figure 4k,l). The expression level of SOX10 in skin transplants 
containing both stromal cells (dermal Fb and ASC) was reduced and accounted for 68 ± 13% 
of all melanocytes (Figure S4).  
 
The effect of TGF-β1 on cultured human melanocytes  
To examine the possible effect of TGF-β1 on human melanocytes in vitro, we tested its 
impact on melanocyte proliferation, morphology and differentiation in vitro. 
Treatment of human epidermal melanocytes with synthetic TGF-β1 (2ng/ml) for 72 
hours in vitro reduced the expression level of TYR from 92 ± 3% to 33 ± 6% (p<0.0001) 
(Figure 5a, d, g) (Martinez-Esparza et al., 1997). The expression of TRP1 was also reduced 
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from 90 ± 3% to 29 ± 2% (p<0.0001) (Figure 5b,e,g) (Martinez-Esparza et al., 1997) as 
compared to control cells cultured in melanocyte medium. However, treatment with TGF-β1 
did not significantly alter the expression of TRP2: 98 ± 2% vs. 95 ± 4% (p=0.2926) (Figure 
5c,f,g).  
 In addition we found that the overall number of melanocytes appeared lower in the 
TGF-β1 treated group (88 ± 8 vs. 19 ± 3 cells/field; p=0.0002) (Figure 5h). We also observed 
morphological changes elicited by TGF-β1 (Figure 5d-f). Whereas untreated melanocytes 
exhibited a pronounced cell body and multiple dendrites, the TGF-β1 treated melanocytes 
appeared mostly as spindle shaped, bipolar cells exhibiting elongated dendrites.  
 
Discussion 
Skin pigmentation is a central issue in the production of bio-engineered, autologous clinically 
applicable dermo-epidermal skin substitutes. To study pigmentation in those substitutes in a 
close to physiological context, we investigated the impact of distinct stromal cell types on 
skin color. Given the fact that ASC are derived from the subcutis, we asked whether these 
cells that physiologically do not directly interact with the epidermis, would support epidermal 
pigmentation efficiently and in all aspects. This was of particular interest as ASC represent 
an abundant cell source and can be used as a substitute for dermal fibroblasts, especially if 
the latter are limited in number. To gain more insight into this matter, we bio-engineered 
pigmented dermo-epidermal skin substitutes (melDESS) containing epidermal melanocytes 
and keratinocytes, and differing in the distinct types of stromal cells in the dermal part 
(Biedermann et al., 2015b). The overall results revealed an anti-melanogenic effect of ASC. 
This effect can be explained by a significant inhibition of melanocyte proliferation, 
differentiation, and melanogenesis. 
 We demonstrated that trophic factors secreted by ASC, in particular TGF-β1, maintain 
melanocytes in an immature, progenitor-like state, thus inhibiting melanin synthesis. 
Accordingly, we observed a strong down-regulation of TYR and TRP1 in human melanocytes 
treated in vitro with medium containing synthetic TGF-β1 (Martinez-Esparza et al., 1997).  
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These findings may well point to a paracrine mechanism induced, perhaps not exclusively, 
but at least to a significant degree, by an increased TGF-β1 concentration.  
Further, we cannot exclude that other growth factors or cytokines secreted by ASC 
such as DKK1, TNF-α, IL-6, or ASIP, which are known inhibitors of melanin synthesis and 
melanosome transfer (Kim et al., 2008a), might exert a combinatorial effect on melanocytes. 
Nevertheless, the concentration of those factors in ASC-CM is not high enough to play a 
crucial role in in the whitening of skin transplants in this study (Kilroy et al., 2007, Kim et al., 
2008a, Martinez-Esparza et al., 1997, Martinez-Esparza et al., 1998). 
Interestingly, already the macroscopic evaluation of the skin transplants containing 
ASC revealed massively reduced skin pigmentation in vivo, resulting in an almost non-
pigmented “white” epidermis. This phenomenon was partially compensated by mixing dermal 
fibroblasts with ASC (in a ratio of 1:1). The key enzymes involved in melanin synthesis – 
TYR and TRP1, were significantly reduced in melDESS containing ASC. Similar findings 
showing a suppression of TYR and TRP1 after the treatment with ASC-CM were described 
by Kim et al. in B16 mouse melanoma cells,  growing on cell culture plastic, hence in a 2D in 
vitro setting (Kim et al., 2008a). 
In human skin epidermal melanocytes exist in distinct maturation states. We and 
others have demonstrated that SOX9 is expressed in a subpopulation of melanocytes and 
that this correlates with the presence of MelanA+ and PMEL+ mature cells in the epidermis 
and in the hair matrix of normal (non-palmoplantar) human skin (Biedermann et al., 2015a, 
Krahl and Sellheyer et al., 2010). In contrast, SOX10 plays an important role during the early 
development of melanocytes in the neural crest, and is still expressed in immature 
melanocytes in the epidermis (Greenhill et al., 2011, Harris et al., 2013). However, SOX10 
expression was detected only in approximately 1 of 6 melanocytes in normal human skin 
(Hasegawa et al., 2008). In our study, the presence of ASC significantly decreased the 
proportion of SOX9-positive melanocytes in melDESS, whereas the fraction of immature 
SOX10 expressing melanocytes was significantly increased. Interestingly, Cook et al. 
demonstrated that cultured immature melanoblasts derived from human neonatal foreskin 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
12 
also expressed SOX10 at high levels, which decreases as these cells differentiate into 
mature melanocytes (Cook et al., 2003).  
In conclusion it can be stated that the mesenchyme (the stroma) matters when it 
comes to the regulation of epidermal melanocyte development in bio-engineered skin (see 
also Yamaguchi et al., 2005). In addition it is the cellular composition of the dermal stroma 
which determines the ratio of mature and immature melanocytes, hence their capability to 
produce, process, and transfer melanin to keratinocytes (Plonka et al., 2009, Yamaguchi and 
Hearing et al., 2009). We have demonstrated here that TGF-β1 plays a central role in this 
regulation. 
 Previously we have shown that the composition and properties of a particular stroma 
also varies significantly with respect to its body site (Biedermann et al., 2015b). As a 
consequence we need to consider both, from which dermal layer the stromal cells are 
derived, and from which area of the body stromal cells are isolated, to bio-engineer a skin 
graft that optimally matches the color of the particular skin region. As a consequence of 
these insights and conclusions, we would like to expand the current concept of the Epidermal 
Melanin Unit (EMU) to the novel concept of the Dermo-Epidermal Melanin Unit (DEMU). The 
DEMU consists of a given melanocyte that is guided not only by keratinocytes but also by 
underlying stromal cells.  
 
Materials and Methods 
Human skin and adipose tissue samples 
The study was conducted according to the “Declaration of Helsinki Principles” and after 
permission by the ethic commission of the Canton Zurich. Parents gave informed consent to 
use skin samples. The human foreskins used were obtained from dark skin pigmentation 
types from patients 1 to 16 years of age.  
Human subcutaneous adipose tissue samples were obtained from fat excisions from 
healthy human donors (between 18 and 68 years of age), female or male, mostly from 
abdominal body location, all of them undergoing a surgical excision operation. All donors 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
13 
gave their informed consent and the study protocol was approved by the local ethical 
committee (EKBB, Ref. 78/07 and 2006-192NMA [extended in 2009]). 
 
Isolation and culturing of primary cells 
The dark pigmented skin samples were used for the isolation of human epidermal 
melanocytes, keratinocytes, and dermal fibroblasts as previously described by Bottcher-
Haberzeth et al., 2013).  
Adipose stromal cells (ASC) were obtained after a monolayer expansion of freshly isolated 
stromal vascular fraction (SVF) as previously described by Klar et al., 2014.  
 
A more complete and detailed description of the methods is included in Supplementary 
Materials and Methods. 
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Figure legends 
 
Figure 1 Effect of ASC-CM on the expression of melanocyte markers and melanin content. 
(a-f) Human primary melanocytes were cultured in either melanocyte medium (a-c) or in 
ASC-CM (d-f). Melanocytes were stained for: PMEL (red), and TYR, or TRP1 or TRP2 
(green). (g) When cultured in melanocyte medium, melanocytes expressed TYR (94±3.1%) 
(a,g), TRP1 (97±4.8%) (b,g), and TRP2 (97±2.5%) (c,g). In ASC-CM the expression of TYR 
(8±2.9%) (d,g) and TRP1 (9±2.4%) (e,g) was markedly reduced, whereas TRP2 expression 
was only slightly reduced (81±5.7%) (f,g). Blue: cell nuclei. Scale bars=50 µm. Error bars: 
mean +/- SD. (h) Melanocyte pellets after incubation in melanocyte medium (left), ASC-CM 
(middle) followed by melanocyte medium (right) for 1week. (i) The melanin content was 
extracted from melanocytes and measured by spectrophotometer at 405nm.  
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Figure 2 Analysis of TGF-β1 expression in dermal fibroblasts (Fb) and ASC. (a) Comparison 
of TGF-β1 mRNA expression in cultured dermal Fb and ASC by reverse transcription-PCR 
(RT-PCR) (green inset). GAPDH was used as an internal control. (b) Relative expression 
levels of TGF-β1 mRNA calculated as a normalized area of TGF-β1 peak. (c) Western blot 
analysis of TGF-β1 protein isolated from cell lysates of cultured dermal Fb and ASC. (d) 
ELISA of TGF-β1 protein isolated from supernatants of cultured dermal Fb and ASC. Error 
bars: mean +/- SD. 
 
Figure 3 Assessment of skin pigmentation of different melDESS in vivo. (a-c) Macroscopic 
view of dermal Fb, dermal Fb/ASC, and ASC melDESS 5 weeks post-transplantation. (d-f) 
Fontana-Masson staining demonstrated the highest melanin concentration in basal layer 
cells of dermal Fb-constructs (d), whereas melanin was less abundant or absent in dermal 
Fb/ASC or ASC-constructs, respectively (e-f). Only the dermal Fb-group displayed melanin in 
supranuclear caps suprabasally (d, white arrows, inset), while other melDESS showed 
random or no suprabasal melanin distribution, respectively (e-f, white arrows, insets). White 
dotted line: basement membrane. (g-i) MITF-staining (red) confirmed even melanocyte (black 
arrows) distribution throughout all melDESS basal layers and revealed differences 
debetween dermal Fb (18±4), dermal Fb/ASC (12±5), and ASC (8±3) melDESS (j). Scale 
bars=50 µm, insets=10 µm. n=4, 24 rats. 
 
Figure 4 Expression of melanocyte differentiation markers in melDESS in vivo. (a-c) The 
number of TYR+PMEL+ (white arrows) melanocytes was significantly decreased (11±5% vs. 
98±5%, p<0.0001) in ASC skin substitutes versus dermal Fb group. (d-f) Comparison of 
TRP1 expression of PMEL+ melanocytes of dermal Fb (d) and ASC (e) skin substitutes. (g-i) 
SOX9, a marker of mature melanocytes, was rarely expressed in PMEL-positive 
melanocytes, when the skin substitute were constructed using ASC alone (40 ± 1%), and 
strongly expressed in the dermal Fb group (95±7%, p<0.0001). (j-l) A significantly higher 
number of SOX10+ PMEL+ immature melanocytes was detected in melDESS containing ASC 
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(81±13%) than dermal Fb (39±14%, p<0.0001). Scale bars=50µm, inset =10 µm. Error bars: 
mean +/- SD, n=4, 24 rats. 
 
Figure 5 The impact of TGF-β1 on the marker expression in cultured melanocytes. (a-f) 
Human primary melanocytes were cultured either in melanocyte medium (a-c) or treated with 
2ng/ml TGF-β1 (d-f) for 72 hours in vitro. (g) The TGF-β1 treatment significantly reduced the 
expression of TYR (33±6% vs. 92±3%, p<0.001) and TRP1 (29± 2% vs. 90±3%, p<0.001) in 
melanocytes. The expression of TRP2 was not significantly changed by the treatment 
(95±4%) as compared to control cells (98±2%, p: ns). (h) TGF-β1 reduced the cell density of 
melanocytes from 88±8 to 19±3 cells per field (p<0.001). Blue: cell nuclei. Error bars: mean 
+/- SD, n=3. 
 
Figure 6 Hypothetical scheme showing stromal-epithelial interactions in two different 
melDESS models in vivo. (a) Control skin model constructed with dermal Fb, keratinocytes 
and melanocytes. Dermal Fb secrete low levels of TGF-β1 and support growth and 
differentiation of epidermal melanocytes. Hence, dermal Fb facilitate dark pigmentation of 
skin substitutes in vivo. (b) Skin model constructed with ASC, keratinocytes and 
melanocytes. ASC exhibit strong inhibitory effects on melanocytes in the epidermis due to a 
high secretion of TGF-β1. This cytokine decreases the pigmentation of skin substitutes in 
vivo by inhibiting the proliferation as well as TYR and TRP1 activity in melanocytes.  
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